38
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery

, MD, , MD, , MD, , MD PhD, , MD PhD & , MD PhD
Pages 590-594 | Received 08 Aug 2016, Accepted 01 Dec 2016, Published online: 15 Apr 2021
 

Abstract

Background

The aim was to evaluate the effect of diquafosol on tear film parameters and corneal aberrations after cataract surgery.

Methods

This retrospective, comparative, observational case series included patients who underwent cataract surgery with or without peri‐operative use of diquafosol three per cent ophthalmic solution. Patients in group I (31 eyes) were treated with diquafosol three per cent ophthalmic solution six times a day from one week before surgery to three months after surgery. Patients in group II (33 eyes) underwent cataract surgery without being administered diquafosol. Tear film break‐up time (BUT), the ocular surface disease index (OSDI), the Oxford Scheme score, Schirmer's test I and corneal aberrations were determined before and at one and three months post‐surgery.

Results

In group I, the BUT, OSDI and Oxford Scheme score showed significant improvement at one and three months post‐surgery (p = 0.002 for BUT at one month and three months, p = 0.023 and p = 0.049 for OSDI at one month and three months and p = 0.001 and p = 0.026 for Oxford Scheme at one month and three months), compared to baseline. In group II, the BUT, OSDI and Oxford Scheme score did not show any significant improvement during the follow‐up period. In both groups, Schirmer's test I significantly decreased at three months post‐surgery (p = 0.011 for group I and p = 0.034 for group II), compared to baseline. There were significant differences in the BUT and OSDI between the groups at three months post‐surgery (p = 0.037 for and p = 0.011 for ). Regarding the corneal aberration, there were no significant differences between the groups at three months post‐surgery.

Conclusion

Peri‐operative application of diquafosol three per cent ophthalmic solution may prevent dry eye‐related ocular surface changes accompanied by improvement of ocular symptom. No definite changes in corneal aberrations were noted.

ACKNOWLEDGEMENT

This work was supported by a grant of the Korean Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea (HI14C2044).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.